SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-18-021162
Filing Date
2018-04-18
Accepted
2018-04-18 16:11:18
Documents
2
Period of Report
2018-04-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tv491341_8k.htm 8-K 23699
2 EXHIBIT 10.1 tv491341_ex10-1.htm EX-10.1 30780
  Complete submission text file 0001144204-18-021162.txt   56133
Mailing Address 483 BAY STREET N105 TORONTO A6 M5G2C9
Business Address 483 BAY STREET N105 TORONTO A6 M5G2C9 1.416.640.7887
Bionik Laboratories Corp. (Filer) CIK: 0001508381 (see all company filings)

IRS No.: 271340346 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 000-54717 | Film No.: 18761323
SIC: 3842 Orthopedic, Prosthetic & Surgical Appliances & Supplies